Literature DB >> 33492732

Protein expression alteration in hippocampus upon genetic repression of AMPKα isoforms.

Wenzhong Yang1, Xueyan Zhou1, Xin Wang1, Jingyun Lee2,3, Dan Wu4, Peiqing Sun4, Cristina M Furdui2, Tao Ma1,5,6.   

Abstract

The AMP-activated protein kinase (AMPK) is a molecular sensor to help maintain cellular energy homeostasis. AMPK is a heterotrimeric complex and its enzymatic catalytic subunit includes two isoforms: α1 and α2. Dysregulation of AMPK signaling is linked to neuronal diseases characterized with cognitive impairments. Emerging evidence also suggest isoform-specific roles of AMPK in the brain. AMPK regulates protein synthesis, which is critical for memory formation and neuronal plasticity. However, the consequence of altering AMPK activity on the translation of specific proteins in the brain is unknown. Here, we use unbiased mass spectrometry-based proteomics approach to analyze protein profile alterations in hippocampus and prefrontal cortex of transgenic mice in which the genes for the two AMPKα isoforms are conditionally deleted. The study revealed identities of proteins whose expression is sensitive to suppression of AMPKα1 and/or α2 isoform. These data may serve as a basis for future in-depth study. Elucidation of the functional relevance of the alteration of specific proteins could provide insights into identification of novel therapeutic targets for neuronal disorders characterized with AMPK signaling dysregulation and impaired cellular energy metabolism.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  AMPK; hippocampus; protein synthesis; proteomics; signal transduction

Mesh:

Substances:

Year:  2021        PMID: 33492732      PMCID: PMC8900146          DOI: 10.1002/hipo.23305

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  23 in total

Review 1.  Biochemical mechanisms for translational regulation in synaptic plasticity.

Authors:  Eric Klann; Thomas E Dever
Journal:  Nat Rev Neurosci       Date:  2004-12       Impact factor: 34.870

Review 2.  The role of protein synthesis during the labile phases of memory: revisiting the skepticism.

Authors:  Cristina M Alberini
Journal:  Neurobiol Learn Mem       Date:  2007-10-24       Impact factor: 2.877

3.  Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility.

Authors:  Mimi A Trinh; Hanoch Kaphzan; Ronald C Wek; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Cell Rep       Date:  2012-05-24       Impact factor: 9.423

4.  Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.

Authors:  Yunhui Hu; Xin Cheng; Shuangjing Li; Yuan Zhou; Jianxiang Wang; Tao Cheng; Ming Yang; Dongsheng Xiong
Journal:  Cancer Chemother Pharmacol       Date:  2013-09-08       Impact factor: 3.333

5.  Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.

Authors:  Wenzhong Yang; Xueyan Zhou; Helena R Zimmermann; Douglas R Cavener; Eric Klann; Tao Ma
Journal:  Neurobiol Aging       Date:  2016-02-13       Impact factor: 4.673

Review 6.  AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

7.  A role for the cytoplasmic polyadenylation element in NMDA receptor-regulated mRNA translation in neurons.

Authors:  D G Wells; X Dong; E M Quinlan; Y S Huang; M F Bear; J D Richter; J R Fallon
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 8.  AMPK in Health and Disease.

Authors:  Gregory R Steinberg; Bruce E Kemp
Journal:  Physiol Rev       Date:  2009-07       Impact factor: 37.312

9.  Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice.

Authors:  Helena R Zimmermann; Wenzhong Yang; Nicole P Kasica; Xueyan Zhou; Xin Wang; Brenna C Beckelman; Jingyun Lee; Cristina M Furdui; C Dirk Keene; Tao Ma
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

10.  Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.

Authors:  Brenna C Beckelman; Wenzhong Yang; Nicole P Kasica; Helena R Zimmermann; Xueyan Zhou; C Dirk Keene; Alexey G Ryazanov; Tao Ma
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

View more
  1 in total

1.  Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity.

Authors:  Maria Berrocal; Lucia Saez; Ana M Mata
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.